biote Corp. (BTMD): auditor change — biote Corp. restating 2022 Q2/Q3 results; earnout liability error, EPS revision

biote Corp.

Audit committee determined Q2 and Q3 2022 unaudited financials should no longer be relied upon due to earnout valuation error.
Error overstated earnout liability and gain/loss from change in fair value; restatement to reduce both.
Changes in fair value of warrant and earnout liabilities will be attributed to operating subsidiary Holdings, not parent.
Restatement will reduce basic and diluted earnings per share; no impact on revenue, operating income, or cash flows.
Company does not believe the error stems from a material weakness in internal controls.

item 4.02

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

biote Corp. reported that prior financial statements should not be relied upon.

Action: non reliance

Exact text from the filing

concluded that the Company’s previously issued unaudited interim condensed consolidated financial statements as of and for the three and six months ended June 30, 2022 and as of and for the three and nine months ended September 30, 2022 (the “Affected Financials”), each as previously filed with the SEC within the respective quarterly report on Form 10-Q, should no longer be relied upon

View on SEC.gov

21 auditor changes filed in the last 30 days. Browse all auditor changes →

biote Corp. filing history →

Source: SEC EDGAR

accession 0001193125-23-079227

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.